Navigation Links
Researchers discover common cell wall component in Chlamydia bacteria
Date:12/11/2013

Researchers studying Chlamydia trachomatis bacteria, which cause the sexually transmitted infection chlamydia as well as infectious blindness, have confirmed that the bacteria containand, in fact, cannot function withoutthe common molecule peptidoglycan, a structural component found in the cell wall of many bacteria. This finding puts an end to years of uncertainty about whether Chlamydia bacteria, like almost all bacterial species, rely on peptidoglycan to reproduce and to maintain their shape and structure. In addition, the novel method the investigators used may be adapted to further examine the molecule's role in the structure and function of other bacteria.

Scientists had long known that Chlamydia infections could be treated with antibiotics that block peptidoglycan synthesis, but previous attempts to detect the molecule in the bacteria were unsuccessfulan apparent paradox known as the "chlamydial anomaly." In the new study, researchers at the Uniformed Services University of the Health Sciences and Indiana University modified certain amino acids, the building blocks of peptidoglycan, by labeling them with chemicals that can be detected using a fluorescent dye. When fed to growing Chlamydia bacteria, the modified amino acids glowed as they were incorporated into peptidoglycan, indicating the regions where the molecule was being produced and confirming its presence.

In addition to helping resolve the chlamydial anomaly, this method can be used to examine other aspects of peptidoglycan production in Chlamydia bacteria. This technique may also be adapted to enhance visualization of peptidoglycan in other bacterial species, the study authors write.

The work, published Dec. 11 in Nature, was supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of General Medical Sciences, both of the National Institutes of Health.


'/>"/>

Contact: Nalini Padmanabhan
padmanabhannm@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert  

Page: 1

Related medicine news :

1. Researchers at Mount Sinai Say a New Strain of Bird Flu Packs a Punch Even After It Becomes Resistant to Drugs
2. OHSU researchers develop new drug approach that could lead to cures for wide range of diseases
3. Keep on exercising, researchers advise older breast cancer survivors
4. CU researchers may have discovered a plan to disable Menieres disease
5. Norwegian brain researchers share Horwitz prize
6. RI researchers validate tool for pain assessment in patients following cardiac surgery
7. University of California Researchers Validate Automated Breast Density Software
8. UAlberta researchers uncover why combination drug treatment ineffective in cancer clinical trials
9. Researchers identify fundamental differences between human cancers and genetically engineered mouse models of cancer
10. UEA researchers receive share of £1.26 million to reduce animal experimentation for drug development
11. Prostate cancer stem cells are a moving target, UCLA researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers discover common cell wall component in Chlamydia bacteria
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds ... the launch of a new DRTV campaign with Belly Bands. , Having a dog ... from sprays to puppy pads and find nothing works, get Belly Bands, the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 ... ... today announced the availability of the company's lighter, sleeker next generation LYNX VR ... assembly plant. , Improvements in design and manufacturing not only reduce the ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... 05, 2016 , ... After years as an active staff surgeon and having ... surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery at ... term as chief and began a second three-year term in January of 2016. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to ... may be safer than regular municipal or well water. The recent experience with lead ... Kleyne, could go a long way toward increasing public acceptance of recycled waste water ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016  Aethlon Medical, Inc. (Nasdaq: ... biofiltration devices to treat life-threatening diseases, today announced ... ended December 31, 2015. --> ... set forth in our last quarterly call, we ... our long-term objective to establish the Aethlon Hemopurifier® ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
Breaking Medicine Technology: